These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17242700)

  • 1. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Kommoss S; du Bois A; Ridder R; Trunk MJ; Schmidt D; Pfisterer J; Kommoss F;
    Br J Cancer; 2007 Jan; 96(2):306-13. PubMed ID: 17242700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.
    Kusume T; Tsuda H; Kawabata M; Inoue T; Umesaki N; Suzuki T; Yamamoto K
    Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer.
    Dong Y; Walsh MD; McGuckin MA; Cummings MC; Gabrielli BG; Wright GR; Hurst T; Khoo SK; Parsons PG
    Int J Cancer; 1997 Aug; 74(4):407-15. PubMed ID: 9291430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers.
    Korkolopoulou P; Christodoulou P; Lazaris A; Thomas-Tsagli E; Kapralos P; Papanikolaou A; Kalliteraki I; Davaris P
    Eur Urol; 2001 Feb; 39(2):167-77. PubMed ID: 11223676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
    Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
    Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced retinoblastoma gene protein to Ki-67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patients.
    Konstantinidou AE; Korkolopoulou P; Vassilopoulos I; Tsenga A; Thymara I; Agapitos E; Patsouris E; Davaris P
    Gynecol Oncol; 2003 Mar; 88(3):369-78. PubMed ID: 12648589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas.
    Maitra A; Roberts H; Weinberg AG; Geradts J
    Int J Cancer; 2001 Jan; 95(1):34-8. PubMed ID: 11241308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma.
    Cui X; Shirai Y; Wakai T; Yokoyama N; Hirano S; Hatakeyama K
    Hum Pathol; 2004 Oct; 35(10):1189-95. PubMed ID: 15492985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
    Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
    Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
    Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
    Suzuki H; Sugimura H; Hashimoto K
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
    Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
    Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEF6 expression in ovarian carcinoma correlates with poor patient survival.
    Liew PL; Fang CY; Lee YC; Lee YC; Chen CL; Chu JS
    Diagn Pathol; 2016 Aug; 11(1):68. PubMed ID: 27488395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
    Lee K; Jung ES; Choi YJ; Lee KY; Lee A
    J Korean Med Sci; 2010 Oct; 25(10):1449-55. PubMed ID: 20890425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.